Risedronate sodium and Fainting - a phase IV clinical study of FDA data

Summary:

Fainting is found among people who take Risedronate sodium, especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years.

The phase IV clinical study analyzes which people take Risedronate sodium and have Fainting. It is created by eHealthMe based on reports of 7,367 people who have side effects when taking Risedronate sodium from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

7,367 people reported to have side effects when taking Risedronate sodium.
Among them, 63 people (0.86%) have Fainting.


What is Risedronate sodium?

Risedronate sodium has active ingredients of risedronate sodium. It is often used in osteoporosis. eHealthMe is studying from 7,437 Risedronate sodium users for its effectiveness, alternative drugs and more.

What is Fainting?

Fainting (loss of consciousness and postural tone) is found to be associated with 3,399 drugs and 3,156 conditions by eHealthMe.

Number of Risedronate sodium and Fainting reports submitted per year:

Could Risedronate sodium cause Fainting?

Time on Risedronate sodium when people have Fainting *:

  • < 1 month: 20 %
  • 1 - 6 months: 20 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 60 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Fainting when taking Risedronate sodium *:

  • female: 83.05 %
  • male: 16.95 %

Age of people who have Fainting when taking Risedronate sodium *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 17.65 %
  • 60+: 82.35 %

Common drugs people take besides Risedronate sodium *:

  1. Esomeprazole Magnesium: 10 people, 15.87%
  2. Ventolin: 10 people, 15.87%
  3. Coenzyme Q10: 9 people, 14.29%
  4. Meclizine: 9 people, 14.29%
  5. Letrozole: 9 people, 14.29%
  6. Lasix: 9 people, 14.29%
  7. Humira: 9 people, 14.29%
  8. Femara: 9 people, 14.29%
  9. Exemestane: 9 people, 14.29%
  10. Zometa: 9 people, 14.29%

Common side effects people have besides Fainting *:

  1. Breathing Difficulty: 27 people, 42.86%
  2. Joint Pain: 23 people, 36.51%
  3. Pneumonia: 22 people, 34.92%
  4. Nausea (feeling of having an urge to vomit): 21 people, 33.33%
  5. Dizziness: 21 people, 33.33%
  6. Pain: 19 people, 30.16%
  7. Weakness: 16 people, 25.40%
  8. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 15 people, 23.81%
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 15 people, 23.81%
  10. Heart Rate Increased: 14 people, 22.22%

Common conditions people have *:

  1. High Blood Pressure: 13 people, 20.63%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 13 people, 20.63%
  3. Asthma: 10 people, 15.87%
  4. Pain: 9 people, 14.29%
  5. Constipation: 9 people, 14.29%
  6. Urinary Tract Infection: 7 people, 11.11%
  7. Nausea (feeling of having an urge to vomit): 7 people, 11.11%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 11.11%
  9. Cardiac Disorder: 7 people, 11.11%
  10. Type 2 Diabetes: 5 people, 7.94%

* Approximation only. Some reports may have incomplete information.

Do you take Risedronate sodium and have Fainting?

Check whether Fainting is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of Risedronate sodium:

Fainting treatments and more:

COVID vaccines that are related to Fainting:

How severe was Fainting and when was it recovered:

Expand to all the drugs that have ingredients of risedronate sodium:

Common drugs associated with Fainting:

All the drugs that are associated with Fainting:

Common conditions associated with Fainting:

All the conditions that are associated with Fainting:

How the study uses the data?

The study uses data from the FDA. It is based on risedronate sodium (the active ingredients of Risedronate sodium) and Risedronate sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: